Risk surveillance and mitigation: autoantibodies as triggers and inhibitors of severe reactions to SARS-CoV-2 infection

• Asıl Yazarlar: Catherine Chen (Yazar), Aisah Amelia (Yazar), George W. Ashdown (Yazar), Ivo Mueller (Yazar), Anna K. Coussens (Yazar), Emily M. Eriksson (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2021-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract COVID-19 clinical presentation differs considerably between individuals, ranging from asymptomatic, mild/moderate and severe disease which in some cases are fatal or result in long-term effects. Identifying immune mechanisms behind severe disease development informs screening strategies to...